BioSpace News Archive

Press Releases

Umoja Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 7, 2025
·
1 min read
Press Releases

Arcturus Therapeutics Announces Initiation of Dosing in Phase 2 Multiple Ascending Dose Studies for Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency

January 7, 2025
·
8 min read
Press Releases

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

January 7, 2025
·
6 min read
Press Releases

Stoke Therapeutics to Host Webcast to Discuss Successful Global Regulatory Alignment for a Phase 3 Study of Zorevunersen as Potentially the First Disease Modifying Medicine for Dravet Syndrome

January 7, 2025
·
2 min read
Press Releases

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

January 7, 2025
·
5 min read
Press Releases

Adcentrx Therapeutics Announces First Patient Dosed in the Phase 1a/b Study of ADRX-0405, a Potential First-in-Class ADC Targeting STEAP1 for the Treatment of Advanced Solid Tumors

January 7, 2025
·
2 min read
Press Releases

Akeso to Share Global Strategy for New Drug Development at the 43rd J.P. Morgan Healthcare Conference

January 7, 2025
·
2 min read
Press Releases

Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope

January 7, 2025
·
1 min read
Press Releases

Anaconda Biomed Appoints Trent Reutiman New CEO

January 7, 2025
·
3 min read
Press Releases

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

January 7, 2025
·
4 min read